{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:28:11Z","timestamp":1794266891530,"version":"4.9.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ophtha.2021.04.017","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T01:25:15Z","timestamp":1618968315000},"page":"1699-1707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States"],"prefix":"10.1016","volume":"128","author":[{"given":"Angela","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis C.","family":"Porco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha R.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ophtha.2021.04.017_bib1","first-page":"9","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"issue":"3","key":"10.1016\/j.ophtha.2021.04.017_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMcp1302674","article-title":"Herpes zoster","volume":"369","author":"Cohen","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"3 suppl","key":"10.1016\/j.ophtha.2021.04.017_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/erv.10.30","article-title":"Herpes zoster and postherpetic neuralgia","volume":"9","author":"Johnson","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.ophtha.2021.04.017_bib4","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"Morb Mortal Wkly Rep Recomm Rep"},{"issue":"6","key":"10.1016\/j.ophtha.2021.04.017_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"issue":"2 suppl","key":"10.1016\/j.ophtha.2021.04.017_bib6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ophtha.2007.10.009","article-title":"Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity","volume":"115","author":"Liesegang","year":"2008","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ophtha.2021.04.017_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ophtha.2012.09.007","article-title":"Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study","volume":"120","author":"Borkar","year":"2013","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ophtha.2021.04.017_bib8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.mayocp.2013.03.014","article-title":"Herpes zoster eye complications: rates and trends","volume":"88","author":"Yawn","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.ophtha.2021.04.017_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/bjophthalmol-2015-306700","article-title":"Persistent dilemmas in zoster eye disease","volume":"100","author":"Cohen","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2021.04.017_bib10","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.ophtha.2016.03.005","article-title":"Epidemiology of herpes zoster ophthalmicus: recurrence and chronicity","volume":"123","author":"Tran","year":"2016","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ophtha.2021.04.017_bib11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/ICO.0000000000001046","article-title":"Prevalence of ocular manifestations and visual outcomes in patients with herpes zoster ophthalmicus","volume":"36","author":"Szeto","year":"2017","journal-title":"Cornea"},{"issue":"22","key":"10.1016\/j.ophtha.2021.04.017_bib12","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A\u00a0vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ophtha.2021.04.017_bib13","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50\u201359 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ophtha.2021.04.017_bib14","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/cid\/cis638","article-title":"Persistence of the efficacy of zoster vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy","volume":"55","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ophtha.2021.04.017_bib15","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term persistence of zoster vaccine efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ophtha.2021.04.017_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jama.2010.1983","article-title":"Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease","volume":"305","author":"Tseng","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ophtha.2021.04.017_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001420","article-title":"Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study","volume":"10","author":"Langan","year":"2013","journal-title":"PLoS Med"},{"issue":"12","key":"10.1016\/j.ophtha.2021.04.017_bib18","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/infdis\/jiw047","article-title":"Declining effectiveness of herpes zoster vaccine in adults aged \u226560 years","volume":"213","author":"Tseng","year":"2016","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.ophtha.2021.04.017_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/aje\/kwx245","article-title":"Long-term effectiveness of the live zoster vaccine in preventing shingles: a cohort study","volume":"187","author":"Baxter","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"22","key":"10.1016\/j.ophtha.2021.04.017_bib20","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ophtha.2021.04.017_bib21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2021.04.017_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab121","article-title":"Effectiveness of the recombinant zoster vaccine in adults aged 50 and older in the United States: a claims-based cohort study","author":"Sun","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ophtha.2021.04.017_bib24","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.vaccine.2018.02.029","article-title":"Complications of herpes zoster in immunocompetent older adults: incidence in vaccine and placebo groups in two large phase 3 trials","volume":"36","author":"Kovac","year":"2018","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.ophtha.2021.04.017_bib25","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1016\/j.vaccine.2018.09.018","article-title":"Primary care physicians\u2019 experience with zoster vaccine live (ZVL) and awareness and attitudes regarding the new recombinant zoster vaccine (RZV)","volume":"36","author":"Hurley","year":"2018","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ophtha.2021.04.017_bib26","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/ICO.0b013e318283453a","article-title":"Studying physician knowledge, attitudes, and practices regarding the herpes zoster vaccine to address perceived barriers to vaccination","volume":"32","author":"Elkin","year":"2013","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ophtha.2021.04.017_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"10.1016\/j.ophtha.2021.04.017_bib28","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.ophtha.2021.04.017_bib29","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"30","key":"10.1016\/j.ophtha.2021.04.017_bib30","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1002\/sim.7084","article-title":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis","volume":"35","author":"Austin","year":"2016","journal-title":"Stat Med"},{"issue":"28","key":"10.1016\/j.ophtha.2021.04.017_bib31","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.ophtha.2021.04.017_bib32","doi-asserted-by":"crossref","first-page":"ofu049","DOI":"10.1093\/ofid\/ofu049","article-title":"Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States","volume":"1","author":"Suaya","year":"2014","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.ophtha.2021.04.017_bib33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2019.10.001","article-title":"Incidence rate of herpes zoster ophthalmicus: a retrospective cohort study from 1994 through 2018","volume":"127","author":"Kong","year":"2020","journal-title":"Ophthalmology"},{"issue":"14","key":"10.1016\/j.ophtha.2021.04.017_bib34","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1016\/j.vaccine.2020.02.057","article-title":"The adult vaccination landscape in the United States during the Affordable Care Act era: results from a large retrospective database analysis","volume":"38","author":"Aris","year":"2020","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.ophtha.2021.04.017_bib35","first-page":"1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States, 2015","volume":"66","author":"Williams","year":"2017","journal-title":"Morb Mortal Wkly Rep Surveill Summ Wash DC 2002"},{"issue":"4","key":"10.1016\/j.ophtha.2021.04.017_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/ICL.0000000000000041","article-title":"Improving adherence to national recommendations for zoster vaccination through simple interventions","volume":"40","author":"Elkin","year":"2014","journal-title":"Eye Contact Lens"},{"issue":"15","key":"10.1016\/j.ophtha.2021.04.017_bib38","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don\u2019t physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ophtha.2021.04.017_bib39","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ajo.2012.11.022","article-title":"Increasing use of the vaccine against zoster through recommendation and administration by ophthalmologists at a city hospital","volume":"155","author":"Jung","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ophtha.2021.04.017_bib40","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.ophtha.2018.07.003","article-title":"Policy statement: recommendations for herpes zoster vaccine for patients 50 years of age and older","volume":"125","year":"2018","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ophtha.2021.04.017_bib41","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/ICO.0b013e31823cbe6a","article-title":"Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus","volume":"31","author":"Sy","year":"2012","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.ophtha.2021.04.017_bib42","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.ophtha.2018.08.030","article-title":"Reactivation of herpes zoster stromal keratitis after HZ\/su adjuvanted herpes zoster subunit vaccine","volume":"125","author":"Lehmann","year":"2018","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642021002876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642021002876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:11:08Z","timestamp":1758982268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642021002876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0161642021002876"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2021.04.017","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2021.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}